These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17241687)

  • 1. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?
    Ullmann R; Bongiovanni M; Halbwedl I; Fraire AE; Cagle PT; Mori M; Papotti M; Popper HH
    J Pathol; 2003 Nov; 201(3):371-6. PubMed ID: 14595748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
    Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
    Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
    Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
    Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
    Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
    Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical adenomatous hyperplasia of the lung].
    Paklina OV; Galil-Ogly GA; Bershchanskaia AM; Alipchenko LA
    Arkh Patol; 2000; 62(3):21-4. PubMed ID: 10897432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between atypical adenomatous hyperplasia and primary lung cancer.
    Chapman AD; Kerr KM
    Br J Cancer; 2000 Sep; 83(5):632-6. PubMed ID: 10944604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
    Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
    Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonality of atypical adenomatous hyperplasia of the lung.
    Niho S; Yokose T; Suzuki K; Kodama T; Nishiwaki Y; Mukai K
    Am J Pathol; 1999 Jan; 154(1):249-54. PubMed ID: 9916939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.
    Takamochi K; Ogura T; Suzuki K; Kawasaki H; Kurashima Y; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Esumi H
    Am J Pathol; 2001 Nov; 159(5):1941-8. PubMed ID: 11696455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
    Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
    Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression in atypical adenomatous hyperplasia of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
    Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.
    Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K
    Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
    Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
    Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.